• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    logo
    Aurobindo Pharma Ltd.
    17 Aug 2025
    USFDA Observation
    1039.60
    1.70%
    Aurobindo Pharma expects China plant to break even at EBITDA level this year
    Business Line
    "This facility with an initial capacity of 2 bn units plus is ramping up as expected and will begin contributing to revenue in the coming quarters and is expected to break even at the EBITDA level by Q3 FY26"
    Copy LinkShare onShare on Share on Share on
    Aurobindo Pharma Ltd. has lost -33.10% in the last 1 Year
    Aurobindo Pharma expects China plant to break even at Ebitda level in FY26
    Business Standard | 17 Aug 2025
    logo
    Glenmark Pharmaceuticals Ltd.
    15 Aug 2025
    Product Launch
    2000.00
    4.23%
    Glenmark Pharmaceuticals Q1 PAT down 86% dragged by US litigation settlement provision
    Business Line
    Consolidated total revenue from operations in Q1FY26 stood at 3,264.44 crore as against 3,244.19 crore in the same period a year ago.
    Copy LinkShare onShare on Share on Share on
    Glenmark Pharmaceuticals Ltd. has gained 33.56% in the last 3 Months
    Glenmark Pharmaceuticals Q1 Results: Profit Plunges 86%
    NDTV Profit | 14 Aug 2025 1 more
    Glenmark Pharma Q1FY26 profit slumps 86% to 47 cr, revenue down 5%
    Business Standard | 14 Aug 2025
    logo
    Strides Pharma Science Ltd.
    14 Aug 2025
    900.00
    0.45%
    Strides towards Naya Bharat
    Business Line
    Copy LinkShare onShare on Share on Share on
    Strides Pharma Science Ltd. has gained 45.28% in the last 6 Months
    logo
    Anthem Biosciences Ltd.
    14 Aug 2025
    819.50
    1.91%
    Recently listed biotech stock surges 44% against issue price; time to sell?
    Business Standard
    Shares of Anthem Biosciences surged 9 per cent to 820 on the BSE in Thursday's intra-day trade amid heavy volumes after reporting a strong earnings for the quarter ended June 2025.
    Copy LinkShare onShare on Share on Share on
    Anthem Biosciences Ltd. has gained 43.77% in the last 6 Months
    logo
    Shilpa Medicare Ltd.
    14 Aug 2025
    844.50
    0.70%
    Shilpa Medicare share jumps 4% on 1:1 bonus issue; check record date here
    Business Standard
    Shilpa Medicare shares rose after the company announced a 1:1 bonus issue, with the Board approving the proposal in its meeting on August 13, 2025.
    Copy LinkShare onShare on Share on Share on
    Shilpa Medicare Ltd. is trading below its 30 day SMA of 870.7
    Shilpa Medicare Announces 1:1 Bonus Issue After Q1 Profit Triples Check Record Date
    NDTV Profit | 13 Aug 2025
    logo
    Lupin Ltd.
    13 Aug 2025
    1946.60
    3.01%
    Mixed Q1 results for top drug firms amid price erosion, tariff threat
    Business Standard
    Fresh launches boosted growth for players like Lupin, Torrent
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 979 to 987 in Jun 2025 qtr.
    logo
    Pfizer Ltd.
    13 Aug 2025
    5174.00
    1.30%
    Pfizer Q1 Results: Net Profit Climbs 27%, Margins Expand
    Pfizer Q1 Results: Net Profit Climbs 27%, Margins Expand
    NDTV Profit
    The drugmaker's bottom-line soared to Rs 191.75 crore during the April-June period, compared to Rs 150.71 crore for the same period last year.
    Copy LinkShare onShare on Share on Share on
    Pfizer Ltd. has gained 27.73% in the last 6 Months
    logo
    Alkem Laboratories Ltd.
    12 Aug 2025
    5290.00
    0.83%
    Alkem to accelerate its non-US business as part of long-term growth plans: CEO
    Business Line
    Plans to set up a subsidiary in Saudi Arabia
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 535 to 551 in Jun 2025 qtr.
    Alkem Labs Q1 profit rises 22% to 664 cr on India, overseas sales growth
    Business Standard | 12 Aug 2025
    logo
    Granules India Ltd.
    12 Aug 2025
    519.70
    2.34%
    Granules India's Q1 FY26 net profit down 1% at 112 cr
    Business Line
    The total revenue of the Hyderabad-based company increased 3 percent at 1210 crore in the quarter under review as against 1179 crore in the year-ago period
    Copy LinkShare onShare on Share on Share on
    Granules India Ltd.'s price crossed above 200Day SMA today
    logo
    Natco Pharma Ltd.
    12 Aug 2025
    872.00
    0.73%
    Natco Pharma's Q1 FY26 net down 28% at 480 crore
    Business Line
    The total revenue of the Hyderabad based company too declined at 1390 crore as against 1410crore in the year -ago period
    Copy LinkShare onShare on Share on Share on
    Natco Pharma Ltd. has an average target of 1297.50 from 4 brokers.
    more
    loading
    Logo Trendlyne

    Stay ahead of the market

    Company

    PrivacyDisclaimerTerms of Use Contact Us

    Resources

    Blog FAQsStock Market Widgets

    Copyright © 2025 Giskard Datatech Pvt Ltd